human-genome-project
(2)
Brian Gilman Has Spent 25 Years Making Science Easier to Search
Before AI promised to read all of biology, Brian Gilman was already trying to make scientific information usable. At Plex Research, his old obsession has acquired a new engine - and a stricter test: show the evidence.
Tom Willis
Tom Willis, PhD, is a genomics entrepreneur with more than 20 years of company-building experience who became CEO of Arima Genomics in June 2025. A Yale and Stanford physicist turned biotech serial founder, he co-invented Molecular Inversion Probe technology, built two genomics companies from the ground up - ParAllele BioScience (acquired by Affymetrix) and Sequenta (whose ClonoSEQ assay became NCCN-standard for leukemia and lymphoma residual disease testing) - then spent a decade as Venture Partner at Illumina Ventures before stepping in to lead Arima, a company pioneering 3D genomics for cancer diagnostics.